Search results
Results from the WOW.Com Content Network
A World Health Organization infographic that states that hydroxychloroquine does not prevent illness or death from COVID-19. Chloroquine and hydroxychloroquine are anti-malarial medications also used against some auto-immune diseases. [1] Chloroquine, along with hydroxychloroquine, was an early experimental treatment for COVID-19. [2]
The PRISMA flow diagram, depicting the flow of information through the different phases of a systematic review. PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) is an evidence-based minimum set of items aimed at helping scientific authors to report a wide array of systematic reviews and meta-analyses, primarily used to assess the benefits and harms of a health care ...
There are many extensions to the STROBE Statement which cover a variety of different topic domains such as nutritional epidemiology, [5] [6] [7] genetic association studies, [8] rheumatology, [9] [10] molecular epidemiology, [11] infectious disease molecular epidemiology, [12] respondent-driven sampling, [13] routinely collected health data [14] [15] (e.g., health administrative data ...
One of the most notable scientific papers that first popularized hydroxychloroquine as a COVID-19 treatment was retracted from its journal due to ethical and methodological issues. Retractions in ...
A World Health Organization infographic that states that hydroxychloroquine does not prevent illness or death from COVID-19. Chloroquine and hydroxychloroquine are anti-malarial medications also used against some auto-immune diseases. [65] Chloroquine, along with hydroxychloroquine, was an early experimental treatment for COVID-19. [66]
This template should be used for all outbreak, epidemic and pandemic medical cases charts based on {{}} to maintain consistency. It displays horizontal bars for up to 5 different classifications of cases for each valid date or interval.
Overdoses of hydroxychloroquine are extremely rare, but extremely toxic. [11] Eight people are known to have overdosed since the drug's introduction in the mid-1950s, of which three have died. [23] [24] Chloroquine has a risk of death in overdose in adults of about 20%, while hydroxychloroquine is estimated to be two or threefold less toxic. [25]
India's Health Ministry published its Guidelines on COVID-19 management, which included approval of hydroxychloroquine. These guidelines were later criticized by physician Anup Agarwal for "disregarding the evidence [on the drug's inefficacy]".